Searched for
NAPROXEN
For both the compulsive trader and careful investor: 25 stocks to watch if risk appetite returns; some with upside potential, some not- Will the currency cycle help them? Yes, but very selectively: 10 pharma stocks with upside potential of up to 33%
- Real Housewives alum Bethenny Frankel diagnosed with stage 2 chronic kidney disease, urges fans to take health screenings seriously
- Mike Tyson vs Jake Paul match may not happen at all. Here's whyMike Tyson, aged 58, is set to come out of retirement to fight Jake Paul next month. The match will stream on Netflix. However, health issu...15 Oct, 2024, 05.26 PM IST
- Stocks in the news: RIL, Wipro, JSW Steel, Tata Power and Max HealthcareThe government hiked the windfall profit tax on the export of diesel to Rs 7 per litre and brought back a tax on jet fuel exports, but slas...19 Aug, 2022, 07.26 AM IST
- Drug makers Glenmark, Aurobindo recall products in USGlenmark Pharmaceuticals Inc, USA is recalling Fulvestrant injection, Naproxen Sodium Tablets, Chlorzoxazone tablets and Arformoterol Tartr...03 Oct, 2021, 12.20 PM IST
- Drug makers Granules India, Jubilant Cadista recall products in US marketSalisbury-based Jubilant Cadista Pharmaceuticals Inc is a fully-owned subsidiary of Cadista Holdings Inc, which is a part of Noida-based Ju...12 Sep, 2021, 04.52 PM IST
- Granules India gets USFDA nod for sleep aid drugThe US Food and Drug Administration (USFDA) has approved the abbreviated new drug application (ANDA) for Naproxen Sodium and Diphenhydramin...25 Sep, 2020, 04.40 PM IST
- Divi's Labs climbs 3% on minimal impact of USFDA alert on Visakhapatnam unitThe company has initiated necessary measures to address the concerns raised by the US-FDA and is making all efforts to fully meet the compl...27 Mar, 2017, 01.26 PM IST
- Divi's Lab gets US FDA import alert for Visakhapatnam unit: Amit Rajan, Celogen Life ScienceDivi's as we all had the impression that it is bluest of the blue chip but I always based on the observations thought that they qualify for...22 Mar, 2017, 10.31 AM IST
- Divi’s Laboratories nosedives 20%, hits 52-week low on USFDA’s import alertIn a filing to BSE, the drug marker said that the USFDA has exempted the company from making ten drugs.21 Mar, 2017, 09.52 AM IST
- Think before popping the pill! Common painkillers may increase risk of heart failureDrugs like ibuprofen, naproxen, and diclofenac are known to raise the risk of stroke by 19 per cent.29 Sep, 2016, 06.26 PM IST
- Aurobindo Pharma shares end with 3% gains on USFDA nodShares of Aurobindo Pharma ended with 3 per cent gains today after the company got final approval from the USFDA to manufacture and market ...21 Mar, 2016, 06.04 PM IST
- Aurobindo Pharma climbs after USFDA nod for OTC drugThe stock soared 2.31 per cent to Rs 738 on BSE. On NSE too, shares of the company climbed 2.31 per cent to Rs 737.95.21 Mar, 2016, 04.21 PM IST
- Aurobindo Pharma gets USFDA nod for osteoporosis drug"The approved product has an estimated market size of USD 96 million for the twelve months ended January 2016 according to IMS," it said.19 Mar, 2016, 02.58 PM IST
- Divis Labs will maintain stable growth momentum and benefit from weak rupeeThe company is ahead of its peers in margin growth and has recorded a consistent revenue growth of above 30% for the past five quarters.16 Apr, 2012, 08.55 AM IST
- Dr Reddy's may lose $30 mn on US import ban from Mexico plantDr Reddy's Laboratories said that up to $30 million in annual revenues could be impacted due to import ban by USFDA on some products from i...20 Jul, 2011, 08.34 PM IST
- DRL to rope in US cos for OTC drugsDr Reddy’s Laboratories is on course to scale up its private label drug business in the US, riding on the initial success of its tie-up wit...29 Oct, 2007, 12.02 AM IST
- Glenmark gets USFDA approval for anti-cholesterol drugGlenmark Pharmaceuticals Ltd has received US FDA (United States Food and Drug Administration) approval for an anti-cholesterol drug Pravast...16 May, 2007, 03.20 PM IST
- Merck's Vioxx successor equally risky, finds studyMerck & Co’s experimental painkiller, Arcoxia, may carry the same risk of heart attacks and strokes as Vioxx, according to an analysis of 2...14 Sep, 2006, 12.01 AM IST
Load More
